# Navigating Ozempic: Breakthrough Oral Semaglutide Pill Shows Promise for Weight Loss Without Needles Discover the latest groundbreaking developments in GLP-1 medications as our podcast examines the game-changing OASIS-4 clinical trial results published in The New England Journal of Medicine. This episode explores how the new oral form of semaglutide achieved impressive 14-16% weight loss results, rivaling injectable versions like Ozempic and Wegovy. We also cover surprising new research revealing the pancreas's natural GLP-1 production abilities, upcoming patent expirations that could dramatically reduce medication costs, and emerging evidence that semaglutide may protect against diabetic eye disease. Stay informed about regulatory changes affecting compounded versions and learn what these advancements mean for obesity treatment, metabolic health, and diabetes management. Perfect for healthcare providers, patients, and anyone interested in the evolving landscape of weight management medications. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI
